KOL Perspectives: IL-6 inhibitors in Rheumatoid Arthritis

Market: Pharmaceuticals and Healthcare

Global, 29 pages report, published by GlobalData

Report ThumbnailFebruary-2018
KOL Perspectives: IL-6 inhibitors in Rheumatoid Arthritis

Summary

This KOL Insight briefing focuses on perceptions of IL-6 inhibitors in rheumatoid arthritis (RA).

The briefing includes analysis of KOL opinion on the following topic areas -
- Current or anticipated future use of sarilumab in RA
- Current use of tocilizumab in RA
- Expected future change to sarilumab & tocilizumab use
- Comparison of sarilumab & tocilizumab clinical profile in RA
- Non-clinical differentiating factors between

Read More
  • Table of Contents
  • Executive Summary
  • Background
  • Research Panel Composition
  • Results & Implications
  • Appendix
Read More

Please select a license type

Share

Related Products

GlobalDataKOL Perspectives: IL-6 inhibitors in Rheumatoid ArthritisProduct ThumbnailKOL Perspectives: IL-6 inhibitors in Rheumatoid Arthritis, Industry ReportProduct #: 1191005
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2019 Global Market Analyst. All Rights Reserved